1. Home
  2. Southern Africa
  3. South Africa
  • News

AIDS drug resistance under discussion

South African Health Minister Manto Tshabalala-Msimang is meeting with AIDS experts after a recent warning by the Medicines Control Council (MCC) about Nevirapine resistance in HIV-positive mothers.

Ministry of Health spokesman Sibani Mngadi told the South African Press Association: "All these people [AIDS experts] attended the Bangkok conference and they can share with the others findings from other parts of the world."

Concerns about the safety of the drug surfaced when research conducted by the MCC, manufacturer Boehringer Ingelheim and the National Institute for Communicable Diseases revealed that some HIV-positive mothers had developed resistance to the drug, creating uncertainty as to whether transmission of the virus was being blocked or not.

As a result, the MCC recommended a combination of anti-AIDS drugs, rather than a single dose of Nevirapine, for the prevention of mother-to-child transmission of HIV.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join